Evidence map›Paper›PMID 41664776›Full record

ArticleCureus2026

A Medically Managed Case of Acromegaly: A Case Report.

Karam Bdour, Khaldon Al-Sarihin, Nesreen El Issa, Odai Alwraikat, Mohammad Albadarneh, Rania Al-Asa'd, Mu'taz Alwadi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karam BdourEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.
Khaldon Al-SarihinEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.
Nesreen El IssaOpthalomology, Jordanian Royal Medical Services, Amman, JOR.
Odai AlwraikatEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.
Mohammad AlbadarnehEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.
Rania Al-Asa'dEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.
Mu'taz AlwadiEndocrinology and Diabetes, Jordanian Royal Medical Services, Amman, JOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine glands are specialized cells responsible for producing and secreting hormones that serve many functions in various body tissues. The pituitary gland is an endocrine gland located in the brain, composed of anterior and posterior parts, both of which are responsible for the secretion of many hormones. The anterior pituitary gland secretes six hormones. Hypersecretion and undersecretion result in abnormalities in the body. Autonomous growth hormone production due to a pituitary adenoma leads to various changes in tissues and organs. Excess growth hormone results in gigantism during childhood, while in adulthood, it is called acromegaly. In this report, we present a 39-year-old man with a large somatotroph macroadenoma, which was managed entirely with medical therapy, resulting in significant biochemical and anatomical improvement. This case highlights the potential role of combined somatostatin analogs and dopamine agonists in selected patients with acromegaly.

Indexed as

acromegalydopamine agonistsgigantismgrowth hormonegrowth hormone-secreting pituitary adenomainsulin-like growth factor 1pituitary adenomasomatostatins analoguessomatotroph adenoma

Identifiers

PMID41664776
PMCPMC12883221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.